Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2017 / Article

Case Report | Open Access

Volume 2017 |Article ID 9893743 | 3 pages |

Disseminated Mycobacterium chimaera Presenting as Vertebral Osteomyelitis

Academic Editor: Daniela M. Cirillo
Received23 Feb 2017
Accepted06 Apr 2017
Published24 Apr 2017


Mycobacterium chimaera, a member of the Mycobacterium avium complex, is a slow-growing, nontuberculous mycobacterium associated with outbreaks in cardiac-surgery patients supported on heart-lung machines. We report a case of an elderly woman on chronic prednisone who presented with a six-month history of worsening chronic back pain, recurrent low-grade fevers, and weight loss. Imaging identified multilevel vertebral osteomyelitis and lumbar soft-tissue abscess. Abscess culture identified M. chimaera.

1. Introduction

Mycobacterium chimaera is a slow-growing, nontuberculous mycobacterium (NTM) sequevar belonging to the Mycobacterium avium complex (MAC) [1]. M. chimaera has been reported in patients undergoing cardiac surgery, who later develop cardiac and disseminated infection [24]. M. chimaera can contaminate tap water and has been identified growing in water tanks within heater-cooler units of heart-lung machines [57].

Prior reports show that, despite antibiotic and surgical treatment, disseminated M. chimaera has a high mortality rate. Even with antibiotic therapy targeted to in vitro sensitivities, medical therapy often fails to result in clearance. The identification of M. chimaera may be missed in the absence of molecular sequencing diagnostics. While this case represents a description of proven M. chimaera osteomyelitis, it is likely that other cases have occurred and been attributed to other MAC species.

2. Case

A 75-year-old woman with systemic lupus erythematosus was evaluated for two months of chronic, low back pain. She also reported subjective fevers, weight loss, and an initially necrotic, one-centimeter wound on her right calf that developed five months earlier. She had no history of trauma, paraspinal steroid injections, or past cardiac or spine surgery. Medications are significant for prednisone and hydroxychloroquine.

On exam she was afebrile, with normal vitals, mild lumbar tenderness, normal strength, and intact reflexes in the lower extremities and without saddle anesthesia.

Laboratory analysis showed normocytic anemia (hemoglobin 11.6 g/dL), normal white blood cells (5.4 × 109/L), normal platelets (175 × 109/L), hyponatremia (124 mmol/L), and elevated erythrocyte sedimentation rate (106 mm/hr) and C-reactive protein (117 mg/L). She had normal serum complement levels, a negative HIV, and an indeterminate QuantiFERON test.

MRI with and without contrast of the thoracic and lumbar spine revealed multilevel discitis and prevertebral osteomyelitis at L1-2, L2-3, and L5-S1 (Figure 1). An abscess located in L5-S1 (Figure 1(a), white arrow) was aspirated. Culture of the abscess revealed polymorphonuclear cells without organisms on conventional and acid-fast bacilli staining. Bacterial and fungal microscopy of the abscess and blood cultures were obtained. Cryptococcal PCR, Coccidioides antibody, and Mycobacterium tuberculosis polymerase chain reaction were negative.

The patient was started on empiric intravenous vancomycin and ertapenem. On day 12, M. chimaera was identified in the abscess aspirate by culture and sequencing. She was then transitioned to clarithromycin, rifampin, and ethambutol. A new biopsy of the calf wound was positive for M. chimaera. Surgical discectomy, debridement, and fusion were recommended; however, she deferred surgery and was discharged with a prolonged course of antimycobacterials.

3. Discussion

Disseminated infection with M. chimaera has been previously described following cardiac surgery (range of 5 to 40 months to diagnosis after surgery) as vascular graft infection, prosthetic valve endocarditis, or myocarditis [2, 3]. Outbreaks of M. chimaera in patients supported by heart-lung machines have prompted recent investigations identifying water tanks supporting heater-cooler systems as the likely source of infection in these outbreaks [6, 7]. M. chimaera can also cause pulmonary infection, similar to M. avium and M. intracellulare [811]. Initial reports suggested that M. chimaera is more virulent than the other MAC species [1]. This has since been called into question by a larger case series in which M. chimaera was more likely to be a colonizer of the respiratory tract and less likely to cause true infection, compared to the other MAC species [11]. In this series, patients with true respiratory infection due to M. chimaera were more likely to be immunosuppressed (53%), suggesting a more opportunistic pattern of infection [11].

Similar to other MAC species, M. chimaera is typically treated with a prolonged course of clarithromycin, ethambutol, and rifampin. Vertebral osteomyelitis caused by MAC or other NTM often requires surgery, due to either neurologic deficits, spinal instability, or failure of medical treatment [12].

Identification of M. chimaera requires sequencing; therefore, nonsequencing methods may fail to identify the correct Mycobacterium species [3, 11, 13]. A study that retrospectively sequenced samples from patients with diagnosed MAC found that 28% of infections were due to M. chimaera, while 54% and 18% of previously diagnosed MAC infections were due to M. avium and M. intracellulare, respectively [11]. In another retrospective study of patients with prior diagnosis of M. intracellulare, sequencing determined that 143 of the 166 samples attributed to M. intracellulare infection could be reclassified as M. chimaera [13]. Similar to other MAC infections, M. chimaera often presents with fever of unknown origin and weight loss.

Disseminated M. chimaera infection after cardiac surgery may manifest as granulomatous nephritis, granulomatous hepatitis, chorioretinitis, multifocal choroiditis, and pulmonary infection, as well as spondylodiscitis, osteoarthritis, and poststernotomy wound infection [14]. Laboratory characteristics of disseminated M. chimaera include an elevated C-reactive protein, pan-negative conventional blood cultures, with anemia, lymphopenia, and thrombocytopenia, and elevated lactate dehydrogenase, creatinine, and transaminases [24].

The patient in this case presented with a history of chronic nonhealing leg wound months prior to the clinical signs of her vertebral osteomyelitis. Given that the leg wound later grew acid-fast bacilli identified as M. chimaera, her ulcer was likely the first manifestation of the disease, months before diagnosis of spinal involvement. This emphasizes the importance of considering slow-growing NTM species in the evaluation of nonhealing wounds in patients on immune-compromising medications, since conventional pathology and bacterial cultures will fail to make the diagnosis.

Unlike many prior descriptions of patients with M. chimaera, our patient did not have a history of recent surgery or heart-lung bypass. Her chronic immunosuppression with prednisone and hydroxychloroquine was a likely predisposing factor to this infection. She had an elevated CRP and anemia similar to other reports, but she did not have pancytopenia or liver and kidney involvement, as described in other patients with disseminated disease after heart surgery [24]. To our knowledge, this is the first report in the literature of M. chimaera causing vertebral osteomyelitis in a patient without history of cardiac surgery.


MAC: Mycobacterium avium complex
NTM:Nontuberculous mycobacteria.


All authors had access to data and had a role in writing this manuscript.

Conflicts of Interest

The authors declare no conflicts of interest.


The authors thank Dr. Jonathan Flug, M.D., for the expertise and help with the figure.


  1. E. Tortoli, L. Rindi, M. J. Garcia et al., “Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov,” International Journal of Systematic and Evolutionary Microbiology, vol. 54, no. 4, pp. 1277–1285, 2004. View at: Publisher Site | Google Scholar
  2. P. Kohler, S. P. Kuster, G. Bloemberg et al., “Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery,” European Heart Journal, vol. 36, no. 40, pp. 2745–2753, 2015. View at: Publisher Site | Google Scholar
  3. H. Sax, G. Bloemberg, B. Hasse et al., “Prolonged outbreak of Mycobacterium chimaera infection after open-chest heart surgery,” Clinical Infectious Diseases, vol. 61, no. 1, pp. 67–75, 2015. View at: Publisher Site | Google Scholar
  4. Y. Achermann, M. Rössle, M. Hoffmann et al., “Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera,” Journal of Clinical Microbiology, vol. 51, no. 6, pp. 1769–1773, 2013. View at: Publisher Site | Google Scholar
  5. R. J. Wallace Jr., E. Iakhiaeva, M. D. Williams et al., “Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease,” Journal of Clinical Microbiology, vol. 51, no. 6, pp. 1747–1752, 2013. View at: Publisher Site | Google Scholar
  6. R. Sommerstein, C. Rüegg, P. Kohler, G. Bloemberg, S. P. Kuster, and H. Sax, “Transmission of Mycobacterium chimaera from heater-cooler units during cardiac surgery despite an ultraclean air ventilation system,” Emerging Infectious Diseases, vol. 22, no. 6, pp. 1008–1013, 2016. View at: Publisher Site | Google Scholar
  7. S. Haller, C. Höller, A. Jacobshagen et al., “Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016,” Eurosurveillance, vol. 21, no. 17, 2016. View at: Publisher Site | Google Scholar
  8. S. Cohen-Bacrie, M. David, N. Stremler, J.-C. Dubus, J.-M. Rolain, and M. Drancourt, “Mycobacterium chimaera pulmonary infection complicating cystic fibrosis: a case report,” Journal of Medical Case Reports, vol. 5, no. 1, article 473, 2011. View at: Publisher Site | Google Scholar
  9. J. Alhanna, M. Purucker, C. Steppert et al., “Mycobacterium chimaera causes tuberculosis-like infection in a male patient with anorexia nervosa,” International Journal of Eating Disorders, vol. 45, no. 3, pp. 450–452, 2012. View at: Publisher Site | Google Scholar
  10. N. D. Bills, S. H. Hinrichs, T. A. Aden, R. S. Wickert, and P. C. Iwen, “Molecular identification of Mycobacterium chimaera as a cause of infection in a patient with chronic obstructive pulmonary disease,” Diagnostic Microbiology and Infectious Disease, vol. 63, no. 3, pp. 292–295, 2009. View at: Publisher Site | Google Scholar
  11. D. P. Boyle, T. R. Zembower, S. Reddy, and C. Qi, “Comparison of clinical features, virulence, and relapse among Mycobacterium avium complex species,” American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 11, pp. 1310–1317, 2015. View at: Publisher Site | Google Scholar
  12. C.-J. Kim, U.-J. Kim, H. B. Kim et al., “Vertebral osteomyelitis caused by non-tuberculous mycobacteria: predisposing conditions and clinical characteristics of six cases and a review of 63 cases in the literature,” Infectious Diseases, vol. 48, no. 7, pp. 509–516, 2016. View at: Publisher Site | Google Scholar
  13. B. Schweickert, O. Goldenberg, E. Richter et al., “Occurrence and clinical relevance of Mycobacterium chimaera sp. nov., Germany,” Emerging Infectious Diseases, vol. 14, no. 9, pp. 1443–1446, 2008. View at: Publisher Site | Google Scholar

Copyright © 2017 Daphne M. Moutsoglou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1454 Views | 310 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.